Drug profile · INN
avacopan
VYNPENTA (PREVIOUSLY AVACOPANCHEMOCENTRYX)
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
avacopan (VYNPENTA (PREVIOUSLY AVACOPANCHEMOCENTRYX)) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN avacopan
Brand VYNPENTA (PREVIOUSLY AVACOPANCHEMOCENTRYX)
Route ORAL
Formulation CAPSULE
ATC code L04
Frequently asked questions
What is avacopan?
avacopan (VYNPENTA (PREVIOUSLY AVACOPANCHEMOCENTRYX)) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for avacopan?
VYNPENTA (PREVIOUSLY AVACOPANCHEMOCENTRYX) is a marketed brand name for avacopan. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of avacopan?
avacopan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.